MANES, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 4.505
AS - Asia 4.254
EU - Europa 3.292
AF - Africa 291
SA - Sud America 229
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.581
Nazione #
US - Stati Uniti d'America 4.451
VN - Vietnam 1.244
SG - Singapore 1.085
CN - Cina 1.055
GB - Regno Unito 783
IT - Italia 698
DE - Germania 396
HK - Hong Kong 313
SE - Svezia 270
UA - Ucraina 253
FR - Francia 225
IN - India 171
RU - Federazione Russa 158
IE - Irlanda 156
BR - Brasile 152
NL - Olanda 104
CI - Costa d'Avorio 84
ZA - Sudafrica 78
JP - Giappone 68
TG - Togo 62
KR - Corea 59
EE - Estonia 52
JO - Giordania 46
FI - Finlandia 45
CA - Canada 36
PH - Filippine 34
AR - Argentina 33
CH - Svizzera 27
TH - Thailandia 27
BG - Bulgaria 24
SC - Seychelles 24
BD - Bangladesh 21
ID - Indonesia 21
BE - Belgio 18
PL - Polonia 16
IQ - Iraq 15
NG - Nigeria 15
TW - Taiwan 15
AT - Austria 14
CO - Colombia 14
IR - Iran 14
TR - Turchia 14
EC - Ecuador 11
PK - Pakistan 10
SA - Arabia Saudita 9
GR - Grecia 8
MX - Messico 8
ES - Italia 7
VE - Venezuela 6
AU - Australia 5
EG - Egitto 5
MY - Malesia 5
PS - Palestinian Territory 5
UZ - Uzbekistan 5
AL - Albania 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
DZ - Algeria 4
HR - Croazia 4
KE - Kenya 4
LT - Lituania 4
OM - Oman 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
ET - Etiopia 3
HN - Honduras 3
JM - Giamaica 3
MA - Marocco 3
MK - Macedonia 3
PE - Perù 3
RO - Romania 3
UY - Uruguay 3
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
EU - Europa 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
MT - Malta 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TN - Tunisia 2
TZ - Tanzania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
GE - Georgia 1
HU - Ungheria 1
IS - Islanda 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MN - Mongolia 1
MW - Malawi 1
MZ - Mozambico 1
UG - Uganda 1
Totale 12.580
Città #
Singapore 730
Southend 676
Chandler 452
Fairfield 418
Ashburn 410
Hong Kong 298
Santa Clara 243
Ho Chi Minh City 242
Hanoi 237
San Jose 206
Woodbridge 203
Wilmington 195
Dong Ket 188
Houston 182
Beijing 171
Seattle 165
Princeton 162
Dublin 155
Cambridge 145
Ann Arbor 140
Jacksonville 139
Hefei 123
Boardman 98
Bologna 89
Abidjan 84
Lauterbourg 77
Padova 77
Nanjing 74
Milan 70
Westminster 68
Tokyo 63
Lomé 62
Berlin 53
Los Angeles 53
Turin 52
Buffalo 47
Amman 46
Jinan 45
Seoul 42
New York 37
Haiphong 35
Helsinki 35
Saint Petersburg 35
Shenyang 35
Medford 32
Da Nang 29
Hebei 28
Mülheim 28
Dallas 24
Changsha 22
Guangzhou 22
San Diego 22
Nanchang 21
Sofia 21
Hangzhou 20
Jiaxing 20
São Paulo 20
Bern 19
Council Bluffs 19
Des Moines 19
Bengaluru 18
Brussels 18
Redondo Beach 18
Mahé 17
Munich 17
Dearborn 16
Rome 16
Abeokuta 15
Frankfurt am Main 15
The Dalles 15
Tianjin 15
Florence 14
London 14
Montreal 13
Toronto 13
Amsterdam 12
Can Tho 12
Orem 12
Shanghai 12
Warsaw 12
Zhengzhou 12
Johannesburg 11
Monmouth Junction 11
Olalla 11
Paris 11
Biên Hòa 10
Bremen 10
Falkenstein 10
Ningbo 10
Ninh Bình 10
Redmond 10
Chengdu 9
Falls Church 9
Yubileyny 9
Ardabil 8
Bogotá 8
Haikou 8
Hải Dương 8
Norwalk 8
Taiyuan 8
Totale 8.008
Nome #
Antiproliferative effect of sildenafil on human pulmonary artery smooth muscle cells 270
L’angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: 5 anni di esperienza in Italia 263
Complicanze del cateterismo cardiaco destro in pazienti con ipertensione polmonare precapillare di grado severo. 251
A Combined Targeted and Whole Exome Sequencing Approach Identified Novel Candidate Genes Involved in Heritable Pulmonary Arterial Hypertension 243
Lung neovascularity in pulmonary arterial hypertension associated with congenital heart defects and idiopathic pulmonary arterial hypertension: study of 198 patients 240
Angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: un caso clinico paradigmatico 230
Il test acuto di vasoreattività nei pazienti con ipertensione arteriosa polmonare. 229
Combining bosentan and sildenafil in pulmonary arterial hypertension patients failing monotherapy: Real-world insights 229
Pulmonary Arterial Hypertension associated to connective tissue diseases 221
Effetti emodinamici e funzionali dell'epoprostenolo in associazione agli antagonisti recettoriali dell'endotelina e agli inibitori delle fosfodiesterasi-5 220
A meta-analysis of randomized controlled trials in pulmonary arterial hypertension 209
Pulmonary hypertension due to left heart disease: analysis of survival according to the haemodynamic classification of the 2015 ESC/ERS guidelines and insights for future changes 204
Aiming at the appropriate target for the treatment of pulmonary hypertension due to left heart disease 200
Regressione delle alterazioni elettrocardiografiche indicative di ipertrofia ventricolare destra nei pazienti con ipertensione arteriosa polmonare. 198
BMPR2 mutations and survival in pulmonary arterial hypertension: An individual participant data meta-analysis 193
Dissecting histone deacetylase role in pulmonary arterial smooth muscle cell proliferation and migration 193
Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups. 188
Prognostic implications of serial assessments of pulmonary hypertension in severe chronic heart failure. 187
Andamento clinico, emodinamico e dei livelli plasmatici dell’NT-pro BNP in pazienti con ipertensione polmonare precapillare 187
Therapeutic alternatives in chronic thromboembolic pulmonary hypertension: from pulmonary endarterectomy to balloon pulmonary angioplasty to medical therapy. State of the art from a multidisciplinary team 182
A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines 177
Current therapeutic approaches to pulmonary arterial hypertension. 174
Effetti del trattamento con sildenafil nei pazienti con ipertensione arteriosa polmonare idiopatica, associata e cuore polmonare cronico tromboembolico. 173
The endothelin system in pulmonary arterial hypertension. 172
New insights on pulmonary arterial hypertension. 171
Significato prognostico dell'aerea del rigurgito tricuspidalico nei pazienti con ipertensione arteriosa polmonare idiopatica trattati secondo le attuali linee guida. 171
Genere femminile e ipertensione arteriosa polmonare: una relazione complessa Female gender and pulmonary arterial hypertension: a complex relationship 170
Evaluation of pulmonary arterial hypertension. 169
Effetti clinici ed emodinamici del trattamento con sildenafil nei pazienti con ipertensione arteriosa polmonare. 169
Rapid Switch From Intravenous Epoprostenol to Intravenous Treprostinil in Patients With Pulmonary Arterial Hypertension. 168
Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2. 166
BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension. 166
Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension and Angina 166
Sildenafil therapy in patients with porto-pulmonary hypertension 163
Confronto tra antagonista recettoriali selettivi e non selettivi dell'endotelina nel trattamento dell'ipertensione arteriosa polmonare. 159
Pulmonary Arterial Hypertension Associated with Portal Hypertension and HIV Infection: Comparative Characteristics and Prognostic Predictors 157
Cardiologia pediatrica. Problematiche cliniche 157
Pulmonary hypertension in primary Sjogren's syndrome: report of a case and review of the literature. 155
Pulmonary arterial hypertension. Part II: Medical and surgical treatment 155
Effetti del sildenafil in soggetti con cuore polmonare cronico tromboembolico 153
Pulmonary veno-occlusive disease: the role of CT 150
Management of Pulmonary Arterial Hypertension Associated with Congenital Systemic-to-Pulmonary Shunts and Eisenmenger's Syndrome. 147
Reverse remodelling of ECG changes in idiopathic pulmonary arterial hypertension patients responders to chronic treatment with calcium channel blockers 147
Effetti a lungo termine del trattamento con bosentan sulla capacità funzionale e sui parametri emodinamici nei pazienti con ipertensione arteriosa polmonare. 145
Transcatheter aortic valve implantation for severe autograft regurgitation after Ross operation. 145
Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward. 142
Tadalafil in idiopathic or heritable pulmonary arterial hypertension (PAH) compared to PAH associated with connective tissue disease 141
Pulmonary arterial hypertension. Part I: pathobiologic, pathophysiologic, clinical and diagnostic aspects 140
Reply: Left Main Extrinsic Compression in Pulmonary Arterial Hypertension: From Identification to Percutaneous Coronary Intervention Optimization 140
Effetti a lungo termine del trattamento con sildenafil nei pazienti affetti da ipertensione arteriosa polmonare associata a cardiopatie congenite con shunt 139
Exercise training in pulmonary hypertension: improving performance but waiting for outcome 135
The difficult diagnosis of pulmonary vascular disease in heart failure 135
Comparative analysis of clinical trials and evidence-based treatment algorithm for pulmonary arterial hypertension 134
L. Negro, M. Zavatta, C. Bachetti, E. Beciani, M. Palazzini, S. Romanazzi, E. Leci, M. Grossi, A. Marinelli, S. Gambetti, A. Manes, N. Galiè, A. Branzi 133
Conventional Medical Therapies in the treatment of pulmonary hypertension 132
Long-term efficacy and safety of sildenafil in precapillary pulmonary hypertension 131
L-arginine supplementation in pulmonary arterial hypertension 130
Epidemiology of patients referred to a specialised pulmonary hypertension center 130
Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension 129
Prognostic role of haemodynamics at follow-up in patients with pulmonary arterial hypertension: a challenge to current European Society of Cardiology/European Respiratory Society risk tools 128
Pulmonary arterial hypertension in the pediatric age. 127
Current medical therapies in pulmonary arterial hypertension 126
Pulmonary hypertension in heart failure with preserved ejection fraction: a plea for proper phenotyping and further research† 125
New Treatment Strategies for Pulmonary Arterial Hypertension 124
Experience with inheritable pulmonary arterial hypertension in a specialised center 123
Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses. 121
Thrombolysis in high-risk patients with acute pulmonary embolism: underuse of a life-saving treatment in the real-world setting 119
GPs meet rare lung disorders task force factsheet: Pulmonary arterial hypertension 118
Long-term outcomes after pulmonary endarterectomy 118
Pulmonary hypertension 116
Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed. 114
Ipertensione polmonare: Necessità di chiarezza tra definizione emodinamica-fisiopatologica, stima ecocardiografica e diagnosi clinica finale. Pulmonary hypertension and the relationships between hemodynamic-pathophysiologic definitions, echocardiographic estimate and final clinical diagnosis: clarification is needed. 102
Pulmonary Hypertension: Lessons from Adults 102
Pulmonary Hypertension 98
Progressi nel trattamento delle malattie della circolazione polmonare 98
Predictive value of tricuspid regurgitation area in idiopathic pulmonary arterial hypertension patients treated according to current guidelines 93
Malattie del circolo polmonare 87
Chronic Thromboembolic Pulmonary Hypertension and Chronic ThromboembolicPulmonary Disease (CTEPD): Clinical and Interventional Perspective 84
Comparison of different treatment strategies in patients with chronic thromboembolic pulmonary hypertension: a single centre real-world experience 82
Metrics for Success of Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension 78
Progress in the treatment of acute pulmonary embolism and chronic thrombo-embolic pulmonary hypertension/disease 75
Diagnosis of Chronic Thromboembolic Pulmonary Hypertension 68
Confirmation of survival prediction based on 2022 ESC/ERS pulmonary hypertension guidelines new haemodynamic thresholds 65
Influence of age in the assessment of therapeutic response in patients with pulmonary arterial hypertension 59
Totale 12.823
Categoria #
all - tutte 32.917
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.917


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021497 0 0 0 0 0 0 0 0 0 59 49 389
2021/20221.412 104 79 90 132 110 77 30 70 52 113 282 273
2022/20231.820 185 251 80 249 87 145 50 90 346 86 143 108
2023/2024317 25 64 22 30 28 40 24 9 12 24 26 13
2024/20251.884 60 338 225 100 336 86 109 61 32 122 42 373
2025/20263.705 321 373 342 286 481 221 346 117 927 291 0 0
Totale 12.823